Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male~* Indonesian~* Age 18-59 years~* Diagnosis of androgenetic alopecia~* Hamilton-Norwood type III-IV~Exclusion Criteria:~* Use of minoxidil or finasteride topical 1 month prior~* Use of minoxidil or finasteride oral 1 month prior~* Skin infection in the treatment area~* Cosmetic procedures for the treatment of alopecia androgenetic such as platelet rich plasma, laser therapy,or microneedling 3 months prior~* History of keloid

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 59 Years
- Healthy Volunteers: f

Study Arms:
- Minoxidil 5% solution (Type: EXPERIMENTAL): Patients will receive minoxidil 5%, twice a day, for a total duration of 12 weeks.
- Combination therapy of microneedling and minoxidil 5% solution (Type: EXPERIMENTAL): Patients will receive a combination therapy of microneedling and minoxidil 5%. Minoxidil 5%, will be given twice a day for a total duration of 12 weeks. The microneedling treatment will be given every 4 weeks (week 0, week 4, week 8)for a total duration of 12 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).